These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Complex genetic alterations in gastrointestinal stromal tumors with autonomic nerve differentiation. Debiec-Rychter M; Pauwels P; Lasota J; Franke S; De Vos R; De Wever I; Hagemeijer A; Sciot R Mod Pathol; 2002 Jul; 15(7):692-8. PubMed ID: 12118105 [TBL] [Abstract][Full Text] [Related]
29. Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation. Wakai T; Kanda T; Hirota S; Ohashi A; Shirai Y; Hatakeyama K Br J Cancer; 2004 Jun; 90(11):2059-61. PubMed ID: 15150562 [TBL] [Abstract][Full Text] [Related]
30. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524 [TBL] [Abstract][Full Text] [Related]
31. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor]. Ma DL; Liu XH; Bai CG; Xie Q; Feng F Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057 [TBL] [Abstract][Full Text] [Related]
32. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor]. Ma D; Liu X; Cai Z; Xie Q Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499 [TBL] [Abstract][Full Text] [Related]
33. New activating mutation in GI stromal tumors. Lang L Gastroenterology; 2003 Mar; 124(3):596. PubMed ID: 12612892 [No Abstract] [Full Text] [Related]
34. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245 [TBL] [Abstract][Full Text] [Related]
35. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Tarn C; Merkel E; Canutescu AA; Shen W; Skorobogatko Y; Heslin MJ; Eisenberg B; Birbe R; Patchefsky A; Dunbrack R; Arnoletti JP; von Mehren M; Godwin AK Clin Cancer Res; 2005 May; 11(10):3668-77. PubMed ID: 15897563 [TBL] [Abstract][Full Text] [Related]
36. [Gastrointestinal stromal tumors]. Schlemmer M; Milani V; Tschoep K; Fahn W; Wendtner CM Dtsch Med Wochenschr; 2003 Sep; 128(39):2015-9. PubMed ID: 14508696 [No Abstract] [Full Text] [Related]
37. [Gastrointestinal stromal tumors: open problems]. Peparini N; Maturo A G Chir; 2002 Oct; 23(10):357-9. PubMed ID: 12611255 [No Abstract] [Full Text] [Related]
38. [At last, an effective therapy for non-differentiated GI sarcomas (gastro intestinal stromal tumor)]. Des Guetz G; De Mestier P; Pierga JY J Chir (Paris); 2002 Oct; 139(5):268-73. PubMed ID: 12410126 [TBL] [Abstract][Full Text] [Related]
39. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Nakahara M; Isozaki K; Hirota S; Miyagawa J; Hase-Sawada N; Taniguchi M; Nishida T; Kanayama S; Kitamura Y; Shinomura Y; Matsuzawa Y Gastroenterology; 1998 Nov; 115(5):1090-5. PubMed ID: 9797363 [TBL] [Abstract][Full Text] [Related]
40. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. Ma Y; Longley BJ; Wang X; Blount JL; Langley K; Caughey GH J Invest Dermatol; 1999 Feb; 112(2):165-70. PubMed ID: 9989791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]